{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T10:34:39Z","timestamp":1784975679440,"version":"3.55.0"},"reference-count":19,"publisher":"Japanese Society for Lymphoreticular Tissue Research","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCEH","J Clin Exp Hematopathol"],"published-print":{"date-parts":[[2025,9,28]]},"DOI":"10.3960\/jslrt.25032","type":"journal-article","created":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T22:08:13Z","timestamp":1759010893000},"page":"189-194","source":"Crossref","is-referenced-by-count":1,"title":["A therapeutic effect of Forodesine for CNS relapsed primary                    testicular T cell lymphoma after allogeneic transplantation"],"prefix":"10.3960","volume":"65","author":[{"given":"Hiroki","family":"Tsutsumi","sequence":"first","affiliation":[{"name":"Department of Hematology, Saitama Cancer Center, Saitama,                            Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahisa","family":"Kudo","sequence":"additional","affiliation":[{"name":"Department of Hematology, Saitama Cancer Center, Saitama,                            Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuo","family":"Maseki","sequence":"additional","affiliation":[{"name":"Department of Hematology, Saitama Cancer Center, Saitama,                            Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasunobu","family":"Sekiguchi","sequence":"additional","affiliation":[{"name":"Department of Hematology, Saitama Cancer Center, Saitama,                            Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirofumi","family":"Kobayashi","sequence":"additional","affiliation":[{"name":"Department of Hematology, Saitama Cancer Center, Saitama,                            Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2349","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Foss                            FM,                                Zinzani                            PL,                                Vose                            JM                    <i>et al.<\/i> Peripheral T-cell lymphoma. Blood. 2011; 117:                    6756-6767.","DOI":"10.1182\/blood-2010-05-231548"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Cheah                            CY,                                Oki                            Y,                                Fanale                            MA. Novel                    treatments for T-cell lymphoma. Am Soc Clin Oncol Educ Book. 2015;                    e468-e478.","DOI":"10.14694\/EdBook_AM.2015.35.e468"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Cheah                            CY,                                Wirth                            A,                                Seymour                            JF. Primary                    testicular lymphoma. Blood. 2014; 123: 486-493.","DOI":"10.1182\/blood-2013-10-530659"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Zhang                            WL,                                Ma                            S,                                Jug                            R                    <i>et al.<\/i> Primary testicular natural killer\/T-cell lymphoma: A                    CARE-case report and review of literature. Medicine (Baltimore). 2018; 97:                        e0181.","DOI":"10.1097\/MD.0000000000010181"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Deng                            L,                                Xu-Monette                            ZY,                                Loghavi                            S                    <i>et al.<\/i> Primary testicular diffuse large B-cell lymphoma                    displays distinct clinical and biological features for treatment failure in                    rituximab era: a report from the International PTL Consortium. Leukemia. 2016;                    30: 361-372.","DOI":"10.1038\/leu.2015.237"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Baehring                            JM,                                Damek                            D,                                Martin                            EC,                                Betensky                            RA,                                Hochberg                            FH.                    Neurolymphomatosis. Neuro Oncol. 2003; 5: 104-115.","DOI":"10.1215\/S1522851702000170"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Zucca                            E,                                Conconi                            A,                                Mughal                            TI                    <i>et al.<\/i> Patterns of outcome and prognostic factors in primary                    large-cell lymphoma of the testis in a survey by the International Extranodal                    Lymphoma Study Group. J Clin Oncol. 2003; 21: 20-27.","DOI":"10.1200\/JCO.2003.11.141"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Ellin                            F,                                Landstr\u00f6m                            J,                                Jerkeman                            M,                                Relander                            T. Central                    nervous system relapse in peripheral T-cell lymphomas: a Swedish Lymphoma                    Registry study. Blood. 2015; 126: 36-41.","DOI":"10.1182\/blood-2014-12-616961"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Mocikova                            H,                                Pytl\u00edk                            R,                                Benesova                            K                    <i>et al.<\/i> Peripheral T-Cell Lymphomas Involving the Central                    Nervous System: A Report From the Czech Lymphoma Study Group Registry. Front                    Oncol. 2022; 12: 874462.","DOI":"10.3389\/fonc.2022.874462"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Choi                            YJ,                                Shin                            JA,                                Kim                            YH                    <i>et al.<\/i> Neurolymphomatosis of Brachial Plexus in Patients with                    Non-Hodgkin\u2019s Lymphoma. Case Rep Oncol Med. 2013; 2013:                        492329.","DOI":"10.1155\/2013\/492329"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Yi                            JH,                                Kim                            JH,                                Baek                            KK                    <i>et al.<\/i> Elevated LDH and paranasal sinus involvement are risk                    factors for central nervous system involvement in patients with peripheral                    T-cell lymphoma. Ann Oncol. 2011; 22: 1636-1643.","DOI":"10.1093\/annonc\/mdq645"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Gurion                            R,                                Mehta                            N,                                Migliacci                            JC                    <i>et al.<\/i> Central nervous system involvement in T-cell lymphoma: A                    single center experience. Acta Oncol. 2016; 55: 561-566.","DOI":"10.3109\/0284186X.2015.1118656"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Chihara                            D,                                Fanale                            MA,                                Miranda                            RN                    <i>et al.<\/i> The risk of central nervous system relapses in patients                    with peripheral T-cell lymphoma. PLoS One. 2018; 13:                        e0191461.","DOI":"10.1371\/journal.pone.0191461"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Pro                            B,                                Perini                            G. Central                    nervous system prophylaxis in peripheral T-cell lymphoma. Blood. 2010; 115:                    5427.","DOI":"10.1182\/blood-2010-02-266890"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Bhansali                            RS,                                Barta                            SK. Central                    Nervous System Progression\/Relapse in Mature T- and NK-Cell Lymphomas. Cancers                    (Basel). 2023; 15: 925.","DOI":"10.3390\/cancers15030925"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Ma                            H,                                Marchi                            E,                                O\u2019Connor                            OA,                                Lue                            JK. Mature                    T-cell and NK-cell lymphoma involvement of the central nervous system: a single                    center experience. Leuk Lymphoma. 2023; 64: 1964-1970.","DOI":"10.1080\/10428194.2023.2245513"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 Grisariu                            S,                                Avni                            B,                                Batchelor                            TT                    <i>et al.<\/i> Neurolymphomatosis: an International Primary CNS                    Lymphoma Collaborative Group report. Blood. 2010; 115:                    5005-5011.","DOI":"10.1182\/blood-2009-12-258210"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18 Conconi                            A,                                Chiappella                            A,                                Ferreri                            AJM                    <i>et al.<\/i> IELSG30 phase 2 trial: intravenous and intrathecal CNS                    prophylaxis in primary testicular diffuse large B-cell lymphoma. Blood Adv.                    2024; 8: 1541-1549.","DOI":"10.1182\/bloodadvances.2023011251"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19 Doi                            Y,                                Yokota                            T,                                Shibayama                            H                    <i>et al.<\/i> A forodesine-based regimen as a therapeutic option for                    PTCL-NOS with Central nervous system involvement. Leuk Lymphoma. 2022; 63:                    1013-1015.","DOI":"10.1080\/10428194.2021.2005043"}],"container-title":["Journal of Clinical and Experimental Hematopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jslrt\/65\/3\/65_25032\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T04:43:59Z","timestamp":1759553039000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jslrt\/65\/3\/65_25032\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,28]]},"references-count":19,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.3960\/jslrt.25032","relation":{},"ISSN":["1346-4280","1880-9952"],"issn-type":[{"value":"1346-4280","type":"print"},{"value":"1880-9952","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,28]]},"article-number":"25032"}}